BALESTRIERI, PAOLA
 Distribuzione geografica
Continente #
AS - Asia 1.326
NA - Nord America 279
SA - Sud America 180
EU - Europa 151
AF - Africa 11
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.951
Nazione #
SG - Singapore 886
US - Stati Uniti d'America 245
CN - Cina 176
BR - Brasile 137
VN - Vietnam 117
HK - Hong Kong 93
IT - Italia 44
GB - Regno Unito 32
DE - Germania 23
AR - Argentina 17
MX - Messico 15
CA - Canada 13
IN - India 12
EC - Ecuador 10
ID - Indonesia 10
NL - Olanda 10
BD - Bangladesh 7
PL - Polonia 7
JP - Giappone 6
ZA - Sudafrica 6
RU - Federazione Russa 5
UA - Ucraina 5
CO - Colombia 4
ES - Italia 4
FR - Francia 4
PY - Paraguay 4
AU - Australia 3
CZ - Repubblica Ceca 3
PE - Perù 3
SE - Svezia 3
AM - Armenia 2
AT - Austria 2
BW - Botswana 2
CL - Cile 2
EG - Egitto 2
FI - Finlandia 2
IR - Iran 2
JO - Giordania 2
LT - Lituania 2
PK - Pakistan 2
SI - Slovenia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
IQ - Iraq 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MQ - Martinica 1
PH - Filippine 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
VC - Saint Vincent e Grenadine 1
Totale 1.951
Città #
Singapore 116
Hong Kong 88
Hefei 68
Ashburn 62
Beijing 48
Ho Chi Minh City 44
Boardman 34
Hanoi 29
Dallas 27
London 27
Rome 19
Shanghai 19
São Paulo 12
Council Bluffs 11
Los Angeles 10
Mexico City 7
Munich 7
Warsaw 7
Amsterdam 6
Rio de Janeiro 6
San Francisco 6
Seattle 6
Toronto 6
Brooklyn 5
Nuremberg 5
Tokyo 5
Boydton 4
Brasília 4
Buenos Aires 4
Da Nang 4
New York 4
Pune 4
Quito 4
Biên Hòa 3
Cagliari 3
Chicago 3
Guarulhos 3
Hamburg 3
Markham 3
Paris 3
Phoenix 3
Santa Clara 3
Stockholm 3
Amman 2
Apodaca 2
Asunción 2
Atibaia 2
Banī Suwayf 2
Bauru 2
Boston 2
Brno 2
Bắc Giang 2
Bắc Ninh 2
Canberra 2
Canela 2
Caxias do Sul 2
Charlotte 2
Chennai 2
Cotia 2
Curitiba 2
Dhaka 2
Formosa 2
Guiyang 2
Haiphong 2
Hưng Yên 2
Itapevi 2
Johannesburg 2
Lima 2
Limeira 2
Liverpool 2
Ljubljana 2
Magé 2
Maitengwe 2
Medellín 2
New Delhi 2
Ninh Bình 2
São Bernardo do Campo 2
São José 2
São José do Rio Preto 2
Thái Bình 2
Thái Nguyên 2
Vĩnh Tường 2
West Jordan 2
Yerevan 2
Zapopan 2
Agudos 1
Alba Iulia 1
Alvorada 1
Ambato 1
Andradina 1
Angeles City 1
Annapolis 1
Araruama 1
Araçatuba 1
Araçoiaba da Serra 1
Araçuaí 1
Atlanta 1
Baghdad 1
Bahía Blanca 1
Baku 1
Totale 837
Nome #
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 207
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 199
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 113
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 102
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients 99
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 83
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 58
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 55
Psychological distress in inflammatory bowel disease 47
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 45
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 42
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 41
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 40
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 39
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 38
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 36
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study 36
Upadacitinib in Patients With Difficult-to-Treat Crohn’s Disease 35
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study 34
Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy 33
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study 32
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC) 32
Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus 31
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 31
Adalimumab in active ulcerative colitis: A "real-life" observational study 31
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study 30
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 30
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 30
Nutritional aspects in inflammatory bowel diseases 29
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 28
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 28
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 27
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study 27
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 27
Reflux Patterns and Role of Impedance-pH Variables in Predicting PPI Response in Patients With Suspected GERD-Related Chronic Cough 27
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 27
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame 25
Role of Overweight and Obesity in Gastrointestinal Disease 25
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 25
Understanding the relationship between esophageal motor disorders and reflux disease 21
Therapeutic drug monitoring is more cost-effective than a clinically based approach in the management of loss of response to infliximab in inflammatory bowel disease: An observational multicentre study 20
Patients With Extra-Esophageal Symptoms, Compared to NERD Patients With Typical Symptoms and Healthy Volunteers, Arc Characterized by a Higher Number of Reflux Episodes and Higher Proportion of Weakly Acidic and Mixed Reflux 20
REFLUX PATTERN AND ROLE OF IMPEDANCE-PH VARIABLES IN PREDICTING PPI RESPONSE IN PATIENTS WITH SUSPECTED GERD-RELATED CHRONIC COUGH 18
Totale 2.003
Categoria #
all - tutte 13.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 4 0 0 0 0 0 0 0 0 28
2022/202310 0 0 0 0 1 0 0 0 1 0 8 0
2023/202494 4 11 3 5 6 37 3 6 0 7 9 3
2024/20251.031 22 8 37 3 11 23 23 3 72 71 301 457
2025/2026836 159 116 173 272 80 36 0 0 0 0 0 0
Totale 2.003